2 Pages
English

2.1 Million Cardiac Rhythm Patients in Indonesia Spikes the Beat of the CRM Market, Finds Frost & Sullivan

Gain access to the library to view online
Learn more

Description

2.1 Million Cardiac Rhythm Patients in Indonesia Spikes the Beat of the CRM Market, Finds Frost & Sullivan PR Newswire JAKARTA, Indonesia, June 20, 2012 - Pacemakers Emerge the Most Popular Device with 49.6 Per cent of the Sales, Closely Followed by Cardiac Ablation with 42.2 Per cent JAKARTA, Indonesia, June 20, 2012 /PRNewswire/ -- Indonesia has a high prevalence of both communicable and non-communicable diseases; among non-communicable diseases, cardiovascular disease's incidence is 7.2 per cent of the total population of 247 million and it is also the fourth leading cause of mortality. Of these, 2.1 million suffer from disorders caused by the rhythm of heart, signifying vast opportunities for the cardiac rhythm management (CRM) market on a small base. New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), Indonesian Market for Cardiac Rhythm Management, finds that the market earned revenues of $1.75 million in 2011 and estimates this to reach $4.15 million in 2016 at a compound annual growth rate of 18.9 per cent. The occurrence of cardiovascular diseases is on the rise due to sedentary lifestyles, unhealthy eating habits and urbanization. However, changes in healthcare services legislation, revamp in health insurance policies, an aging population, affluent and dormant life style, smoking and the urge to be treated will boost the Indonesian CRM market.

Subjects

Informations

Published by
Reads 3
Language English
2.1 Million Cardiac Rhythm Patients in
Indonesia Spikes the Beat of the CRM Market,
Finds Frost & Sullivan
PR Newswire
JAKARTA, Indonesia, June 20, 2012
- Pacemakers Emerge the Most Popular Device with 49.6 Per cent of the Sales,
Closely Followed by Cardiac Ablation with 42.2 Per cent
JAKARTA, Indonesia
,
June 20, 2012
/PRNewswire/ --
Indonesia
has a high
prevalence of both communicable and non-communicable diseases; among
non-communicable diseases, cardiovascular disease's incidence is 7.2 per cent
of the total population of 247 million and it is also the fourth leading cause of
mortality. Of these, 2.1 million suffer from disorders caused by the rhythm of
heart, signifying vast opportunities for the cardiac rhythm management (CRM)
market on a small base.
New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com),
Indonesian Market for Cardiac Rhythm Management
, finds that the
market earned revenues of
$1.75 million
in 2011 and estimates this to reach
$4.15 million
in 2016 at a compound annual growth rate of 18.9 per cent.
The occurrence of cardiovascular diseases is on the rise due to sedentary
lifestyles, unhealthy eating habits and urbanization. However, changes in
healthcare services legislation, revamp in health insurance policies, an aging
population, affluent and dormant life style, smoking and the urge to be treated
will boost the Indonesian CRM market.
In 2011, single-chamber pacemakers were the most popular device for CRM
due to their low cost, familiarity and simplicity of implantation.
"Both hospitals and healthcare professionals have indicated a preference for
pacemakers, making it the largest segment, with a sale of 417 units,
accounting for 49.6 per cent of the Indonesian CRM market," says Frost &
Sullivan's Consultant, Poornima Srinivasan.
Pacemakers will gain further traction with its use in cardiac resynchronization
therapy due to the product's success rates, efficacy and longevity.
Currently, there are limited interventional cardiology and electrophysiology
centres to perform cardiac rhythm implants.
"To meet the needs of the growing incidence, the Indonesian government is
encouraging private hospitals and foreign participants to establish hospitals in
the country," notes Srinivasan.
"As the rising wealth and population growth necessitate quality healthcare
services in
Indonesia
, the government has decided to extend the maximum
limit for foreign ownership from 47 percent to 67 percent. As a result of this
legislation, more foreign hospitals with sophisticated technologies and
infrastructure are expected to invest in
Indonesia
," says Eugene van de Weerd,
Country Director, Frost & Sullivan –
Indonesia
. "Such a move is expected to
result in more cardiac, oncological, and other surgeries taking place within the
country, thereby curtailing the need for medical treatment abroad." Eugene
concluded.
About Frost & Sullivan